Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell

Tomohisa Suzuki1, Izumi Hide, Akiyo Matsubara

  • 1Department of Pharmacology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.

Insights

Nicotine modulates microglial responses via alpha7 nicotinic acetylcholine receptors (alpha7 nAChRs), enhancing neuroprotective pathways while suppressing inflammatory ones. This suggests a potential role for nicotine in promoting brain health by altering microglial activation states.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglia exhibit dual neuroprotective and neurotoxic functions, influenced by activation state and mediator release.
  • P2X7 receptor stimulation and lipopolysaccharide (LPS) trigger differential Tumor Necrosis Factor (TNF) release from microglia, impacting neuronal health and neuroinflammation.
  • Alpha7 nicotinic acetylcholine receptors (alpha7 nAChRs) are implicated in modulating microglial responses.

Purpose of the Study:

  • To investigate the role of nicotine and alpha7 nAChRs in modulating microglial TNF release and activation pathways.
  • To elucidate the signaling mechanisms downstream of alpha7 nAChR activation in microglia.
  • To explore the potential of nicotine in shifting microglial function towards a neuroprotective phenotype.

Main Methods:

  • Primary rat microglia cultures were used to study nicotine's effects on TNF release.
  • Experiments involved stimulation with P2X7 receptor agonists and LPS, with measurements of TNF mRNA and protein expression.
  • Nicotine's impact on intracellular calcium (Ca2+) levels, phospholipase C (PLC) activity, IP3 receptor signaling, and MAP kinase activation (JNK, p38) was assessed using specific inhibitors and blockers.

Main Results:

  • Nicotine enhanced P2X7 receptor-mediated TNF release but suppressed LPS-induced TNF release, without altering TNF mRNA levels.
  • Nicotine-induced Ca2+ transients in microglia were dependent on alpha7 nAChRs and involved PLC and IP3 receptor signaling, independent of extracellular Ca2+.
  • Nicotine suppressed LPS-induced JNK and p38 MAP kinase activation, while enhancing Ca2+ responses in P2X7 receptor-activated microglia.

Conclusions:

  • Microglial alpha7 nAChRs activate a signaling cascade involving PLC and intracellular Ca2+ release, functioning distinct from conventional ion channels.
  • This novel alpha7 nAChR signaling pathway may underlie nicotine's ability to shift microglia towards a neuroprotective role.
  • Nicotine's modulation of microglia may suppress inflammatory responses and bolster neuroprotective functions, offering therapeutic potential.